Literature DB >> 23070196

Cost-effectiveness of enhanced depression care after acute coronary syndrome: results from the Coronary Psychosocial Evaluation Studies randomized controlled trial.

Joseph A Ladapo, Jonathan A Shaffer, Yixin Fang, Siqin Ye, Karina W Davidson.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23070196      PMCID： PMC3657548          DOI： 10.1001/archinternmed.2012.4448

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  The estimation of a preference-based measure of health from the SF-12.

Authors:  John E Brazier; Jennifer Roberts
Journal:  Med Care       Date:  2004-09       Impact factor: 2.983

Review 2.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

Authors:  A H Briggs; D E Wonderling; C Z Mooney
Journal:  Health Econ       Date:  1997 Jul-Aug       Impact factor: 3.046

3.  Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.

Authors:  Karina W Davidson; Nina Rieckmann; Lynn Clemow; Joseph E Schwartz; Daichi Shimbo; Vivian Medina; Gabrielle Albanese; Ian Kronish; Mark Hegel; Matthew M Burg
Journal:  Arch Intern Med       Date:  2010-04-12

4.  Depression and health-care costs during the first year following myocardial infarction.

Authors:  N Frasure-Smith; F Lespérance; G Gravel; A Masson; M Juneau; M Talajic; M G Bourassa
Journal:  J Psychosom Res       Date:  2000 Apr-May       Impact factor: 3.006

5.  Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.

Authors:  Joost P van Melle; Peter de Jonge; Titia A Spijkerman; Jan G P Tijssen; Johan Ormel; Dirk J van Veldhuisen; Rob H S van den Brink; Maarten P van den Berg
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

6.  Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.

Authors:  J Robert Swenson; Christopher M O'Connor; David Barton; Louis T Van Zyl; Karl Swedberg; Leslie M Forman; Michael Gaffney; Alexander H Glassman
Journal:  Am J Cardiol       Date:  2003-12-01       Impact factor: 2.778

7.  Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial.

Authors:  Wayne Katon; Joan Russo; Elizabeth H B Lin; Julie Schmittdiel; Paul Ciechanowski; Evette Ludman; Do Peterson; Bessie Young; Michael Von Korff
Journal:  Arch Gen Psychiatry       Date:  2012-05
  7 in total
  9 in total

1.  Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.

Authors:  Louis I Hochheiser; Jessie L Juusola; Mark Monane; Joseph A Ladapo
Journal:  Popul Health Manag       Date:  2014-02-25       Impact factor: 2.459

Review 2.  Psychological interventions for coronary heart disease.

Authors:  Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-04-28

3.  A systematic review of economic analyses of psychological interventions and therapies in health-related settings.

Authors:  Leeanne Nicklas; Mairi Albiston; Martin Dunbar; Alan Gillies; Jennifer Hislop; Helen Moffat; Judy Thomson
Journal:  BMC Health Serv Res       Date:  2022-09-07       Impact factor: 2.908

4.  Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial.

Authors:  Karina W Davidson; J Thomas Bigger; Matthew M Burg; Robert M Carney; William F Chaplin; Susan Czajkowski; Ellen Dornelas; Joan Duer-Hefele; Nancy Frasure-Smith; Kenneth E Freedland; Donald C Haas; Allan S Jaffe; Joseph A Ladapo; Francois Lespérance; Vivian Medina; Jonathan D Newman; Gabrielle A Osorio; Faith Parsons; Joseph E Schwartz; Jonathan A Shaffer; Peter A Shapiro; David S Sheps; Viola Vaccarino; William Whang; Siqin Ye
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

5.  Twelve-month cost-effectiveness of telephone-delivered collaborative care for treating depression following CABG surgery: a randomized controlled trial.

Authors:  Julie M Donohue; Bea Herbeck Belnap; Aiju Men; Fanyin He; Mark S Roberts; Herbert C Schulberg; Charles F Reynolds; Bruce L Rollman
Journal:  Gen Hosp Psychiatry       Date:  2014-05-21       Impact factor: 3.238

Review 6.  Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Phillip J Tully; Harald Baumeister
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

7.  Depression screening with patient-targeted feedback in cardiology: The cost-effectiveness of DEPSCREEN-INFO.

Authors:  Christian Brettschneider; Sebastian Kohlmann; Benjamin Gierk; Bernd Löwe; Hans-Helmut König
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

8.  Goal-directed versus outcome-based financial incentives for weight loss among low-income patients with obesity: rationale and design of the Financial Incentives foR Weight Reduction (FIReWoRk) randomised controlled trial.

Authors:  Melanie Jay; Stephanie L Orstad; Soma Wali; Judith Wylie-Rosett; Chi-Hong Tseng; Victoria Sweat; Sandra Wittleder; Suzanne B Shu; Noah J Goldstein; Joseph A Ladapo
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

9.  Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.

Authors:  Sae Takada; Allison J Ober; Judith S Currier; Noah J Goldstein; Tamara B Horwich; Brian S Mittman; Suzanne B Shu; Chi-Hong Tseng; Tara Vijayan; Soma Wali; William E Cunningham; Joseph A Ladapo
Journal:  Prog Cardiovasc Dis       Date:  2020-02-19       Impact factor: 8.194
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.